Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one
- 1 April 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (7) , 1003-1008
- https://doi.org/10.1016/s0960-894x(99)00118-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinoneBioorganic & Medicinal Chemistry Letters, 1998
- Synthesis and Biological Activity of a Novel Series of Nonsteroidal, Peripherally Selective Androgen Receptor Antagonists Derived from 1,2-Dihydropyridono[5,6-g]quinolinesJournal of Medicinal Chemistry, 1998
- Emerging Issues in Androgen Replacement TherapyJournal of Clinical Endocrinology & Metabolism, 1997
- The Intracellular Receptor and Signal Transducers and Activators of Transcription Factor Superfamilies: Novel Targets for Small-Molecule Drug DiscoveryJournal of Medicinal Chemistry, 1995
- Efficacy and tolerability of Casodex in patients with advanced prostate cancerAnti-Cancer Drugs, 1995
- Current clinical studies with a new nonsteroidal antiandrogen, casodexThe Prostate, 1994
- Effects of testosterone supplementation in the aging maleJournal of Clinical Endocrinology & Metabolism, 1992
- Clinical review 34: Androgen treatment of hypogonadal menJournal of Clinical Endocrinology & Metabolism, 1992
- Anti-Androgenicity of Flutamide and its Metabolite Sch 16423Biochemical Society Transactions, 1979
- Biological aspects of antiandrogensJournal of Steroid Biochemistry, 1975